Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jifa Zhang

Showing results (11-20 of 113) with videos related to

Pageof 12
Sort By:
Future Medicinal Chemistry|November 15, 2021
Molecular glues targeting protein degradation pathways for drug discoveryChangyu Ren, Xiaohong Gan, Houfeng Zhou, et al.
Journal of Medicinal Chemistry|November 8, 2022
Small-Molecule Receptor-Interacting Protein 1 (RIP1) Inhibitors as Therapeutic Agents for Multifaceted Diseases: Current Medicinal Chemistry Insights and Emerging OpportunitiesKunyu Shi, Jifa Zhang, Enda Zhou, et al.
Frontiers in Plant Science|February 11, 2026
Creating large <sup>60</sup>Co-γ populations for functional genomics and breeding in wheatQunqun Hao, Simeng Ma, Jifa Zhang, et al.
Bioorganic Chemistry|April 30, 2026
ATI-1 mediated disruption of the VCP-UFL1-Beclin1 axis thwarts autophagy initiation to trigger metabolic catastrophe in autophagy-addicted cancersTong Liu, Min Zhao, Jing Gao, et al.
European Journal of Medicinal Chemistry|June 13, 2022
Dual-target inhibitors of indoleamine 2, 3 dioxygenase 1 (Ido1): A promising direction in cancer immunotherapyYa Zhang, Zelin Hu, Jifa Zhang, et al.
Journal of Medicinal Chemistry|July 25, 2022
Polo-like Kinase 1 Inhibitors in Human Cancer Therapy: Development and Therapeutic PotentialJifa Zhang, Lele Zhang, Jiaxing Wang, et al.
Journal of Medicinal Chemistry|September 11, 2024
Targeting HSP90 for Cancer Therapy: Current Progress and Emerging ProspectsXinqi Liang, Ruixian Chen, Chengdi Wang, et al.
European Journal of Medicinal Chemistry|November 24, 2023
Advances in targeting Phosphodiesterase 1: From mechanisms to potential therapeuticsZiyu Zhu, Wentao Tang, Xuemei Qiu, et al.
European Journal of Medicinal Chemistry|March 2, 2024
Current advances and development strategies of targeting son of sevenless 1 (SOS1) in drug discoveryJialin Wu, Xiaoxue Li, Chengyong Wu, et al.
Journal of Medicinal Chemistry|January 2, 2024
Comprehensive Insights that Targeting PIM for Cancer Therapy: Prospects and ObstaclesLi Chen, Wuyu Mao, Changyu Ren, et al.
Pageof 12

Showing results (11-20 of 113) with videos related to

Sort By:
Pageof 12
Future Medicinal Chemistry|November 15, 2021
Molecular glues targeting protein degradation pathways for drug discoveryChangyu Ren, Xiaohong Gan, Houfeng Zhou, et al.
Journal of Medicinal Chemistry|November 8, 2022
Small-Molecule Receptor-Interacting Protein 1 (RIP1) Inhibitors as Therapeutic Agents for Multifaceted Diseases: Current Medicinal Chemistry Insights and Emerging OpportunitiesKunyu Shi, Jifa Zhang, Enda Zhou, et al.
Frontiers in Plant Science|February 11, 2026
Creating large <sup>60</sup>Co-γ populations for functional genomics and breeding in wheatQunqun Hao, Simeng Ma, Jifa Zhang, et al.
Bioorganic Chemistry|April 30, 2026
ATI-1 mediated disruption of the VCP-UFL1-Beclin1 axis thwarts autophagy initiation to trigger metabolic catastrophe in autophagy-addicted cancersTong Liu, Min Zhao, Jing Gao, et al.
European Journal of Medicinal Chemistry|June 13, 2022
Dual-target inhibitors of indoleamine 2, 3 dioxygenase 1 (Ido1): A promising direction in cancer immunotherapyYa Zhang, Zelin Hu, Jifa Zhang, et al.
Journal of Medicinal Chemistry|July 25, 2022
Polo-like Kinase 1 Inhibitors in Human Cancer Therapy: Development and Therapeutic PotentialJifa Zhang, Lele Zhang, Jiaxing Wang, et al.
Journal of Medicinal Chemistry|September 11, 2024
Targeting HSP90 for Cancer Therapy: Current Progress and Emerging ProspectsXinqi Liang, Ruixian Chen, Chengdi Wang, et al.
European Journal of Medicinal Chemistry|November 24, 2023
Advances in targeting Phosphodiesterase 1: From mechanisms to potential therapeuticsZiyu Zhu, Wentao Tang, Xuemei Qiu, et al.
European Journal of Medicinal Chemistry|March 2, 2024
Current advances and development strategies of targeting son of sevenless 1 (SOS1) in drug discoveryJialin Wu, Xiaoxue Li, Chengyong Wu, et al.
Journal of Medicinal Chemistry|January 2, 2024
Comprehensive Insights that Targeting PIM for Cancer Therapy: Prospects and ObstaclesLi Chen, Wuyu Mao, Changyu Ren, et al.
Pageof 12